MedPath
TGA Approval

PROSTAVAN (162243)

162243

PROSTAVAN

Melaleuca of Australia and New Zealand Pty Ltd

June 5, 2009

Medicine

Medicine

Active

Listed

Active Ingredients

Cucurbita pepo

lycopene

Serenoa repens

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PROSTAVAN (162243) - TGA 批准文号 | MedPath